Largest Clinical Trials companies in Israel by Market Capitalization
Israel
# |
Name |
Market Capitalization |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
|---|---|---|---|---|---|---|---|
| 1 |
USD 280.41 M |
Jan. 14, 2025 | USD 4.00 | 8.11% |
|
Israel |
|
| 2 |
USD 186.28 M |
Jan. 14, 2025 | USD 1.85 | 10.75% |
|
Israel |
|
| 3 |
USD 86.92 M |
Jan. 14, 2025 | USD 2.36 | -1.67% |
|
Israel |
|
| 4 |
USD 35.83 M |
Jan. 14, 2025 | USD 1.90 | -4.04% |
|
Israel |
|
| 5 |
USD 25.48 M |
Jan. 14, 2025 | USD 1.16 | -2.88% |
|
Israel |
|
| 6 |
USD 24.19 M |
Jan. 14, 2025 | USD 0.01 | -11.50% |
|
Israel |
|
| 7 |
USD 23.93 M |
Jan. 14, 2025 | USD 1.03 | -0.96% |
|
Israel |
|
| 8 |
USD 10.10 M |
Jan. 14, 2025 | USD 0.02 | -1.36% |
|
Israel |
|
| 9 |
USD 10.07 M |
Jan. 14, 2025 | USD 0.01 | 0.04% |
|
Israel |
|
| 10 |
USD 4.67 M |
Jan. 14, 2025 | USD 2.82 | -2.08% |
|
Israel |
|
| 11 |
USD 2.40 M |
Jan. 14, 2025 | USD 2.74 | -3.52% |
|
Israel |
Frequently Asked Questions
-
Which Clinical Trials company in Israel has the highest Market Capitalization ?
The Clinical Trials company in Israel with the highest Market Capitalization is Alpha Tau Medical Ltd. (NasdaqCM: DRTS) at USD 280.41 M.
-
Which Clinical Trials company in Israel has the lowest Market Capitalization ?
The Clinical Trials company in Israel with the lowest Market Capitalization is PainReform Ltd. (NasdaqCM: PRFX) at USD 2.40 M.
-
What are the top 10 Clinical Trials companies in Israel by Market Capitalization ?
The top 10 Clinical Trials companies in Israel by Market Capitalization are Alpha Tau Medical Ltd., Compugen Ltd., Entera Bio Ltd., Chemomab Therapeutics Ltd., Enlivex Therapeutics Ltd., BioLineRx Ltd., NeuroSense Therapeutics Ltd., Purple Biotech Ltd., Can-Fite BioPharma Ltd. and Galmed Pharmaceuticals Ltd..
-
What are the bottom 10 Clinical Trials companies in Israel by Market Capitalization ?
The bottom 10 Clinical Trials companies in Israel by Market Capitalization are PainReform Ltd., Galmed Pharmaceuticals Ltd., Can-Fite BioPharma Ltd., Purple Biotech Ltd., NeuroSense Therapeutics Ltd., BioLineRx Ltd., Enlivex Therapeutics Ltd., Chemomab Therapeutics Ltd., Entera Bio Ltd. and Compugen Ltd..